Synthesis of acyclo-C-nucleosides in the imidazo[1,2-a]pyridine and pyrimidine series as antiviral agents

Journal of Medicinal Chemistry

Volumn 39, Issue 14, 1996, Pages 2856-2859

  Gueiffier, Alain ^a,b   Lhassani, Mohammed ^a   Elhakmaoui, Ahmed ^a   Snoeck, Robert ^c   Andrei, Graciela ^c   Chavignon, Olivier ^d   Teulade, Jean Claude ^d   Kerbal, Abdelali ^e   Essassi, El Mokhtar ^f   Debouzy, Jean Claude ^g   Witvrouw, Myriam ^c   Blache, Yves ^a   Balzarini, Jan ^c   De Clercq, Erik ^c   Chapat, Jean Pierre ^a  

^a CNRS   (France)

^b UNIVERSITÉ DE TOURS   (France)

^c REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^d Laboratoire de Pharmacochimie   (France)

^e Sidi Mohamed Ben Abdellah University   (Morocco)

^f FACULTÉ DES SCIENCES   (Morocco)

^g CENTRE DE RECHERCHES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

5 (2 BROMOVINYL) 2' DEOXYURIDINE; 9 (2,3 DIHYDROXYPROPYL)ADENINE; ACICLOVIR; ANTIVIRUS AGENT; CIDOFOVIR; DIDANOSINE; GANCICLOVIR; IMIDAZO[1,2 A]PYRIDINE DERIVATIVE; IMIDAZO[1,2 A]PYRIMIDINE DERIVATIVE; NUCLEOSIDE DERIVATIVE; RIBAVIRIN; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; ARTICLE; CYTOMEGALOVIRUS; DRUG CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; NONHUMAN; STRUCTURE ACTIVITY RELATION; VARICELLA ZOSTER VIRUS; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CERCOPITHECUS AETHIOPS; HELA CELLS; HUMANS; NUCLEOSIDES; PYRIDINES; PYRIMIDINES; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED; VERO CELLS;

EID: 8944242597     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9507901     Document Type: Article

References (18)

1. De Clercq, E. Recent advances in the search for selective antiviral agents. Adv. Drug Res. 1988, 17, 1-59.
2. Chu, C. K.; Butler, S. J. Chemistry and antiviral activities of acyclonucleotides. J. Heterocycl. Chem. 1986, 23, 289-319.
3. (a) Miyasaka, T.; Tanaka, B.; Baba, M.; Hayakawa, H.; Walker, R. T.; Balzarini, J.; De Clercq, E. A novel lead for specific anti-HIV-1 agents: 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine. J. Med. Chem. 1989, 32 (12), 2507-2509.
4. (b) Tanaka, H.; Baba, M.; Ubasawa, M.; Takashima, H.; Sekiya, K.; Nitta, I.; Shigeta, S.; Walker, R. T.; De Clercq, E.; Miyasakia, T. Synthesis and anti-HIV-1 activity of 2-, 3- and 4-substituted analogues of 1-[-(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT). J. Med. Chem. 1991, 34 (4), 1394-1399.
5. (c) Tanaka, H.; Baba, M.; Saito, S.; Miyasaka, T.; Takashima, H.; Sekika, K.; Ubasawa, M.; Nitta, I.; Walker, R. T.; Nakashima, H.; De Clercq, E. Specific anti-HIV-1 "acyclonucleosides" which cannot be phosphorylated: synthesis of some deoxy analogues of 1-[-(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine. J. Med. Chem. 1991, 34 (4), 1508-1511.
6. (a) Gueiffier, A.; Milhavet, J. C.; Blache, Y.; Chavignon, O; Teulade, J. C.; Madesclaire, M.; Viols, H.; Dauphin, G.; Chapat, J. P. Synthesis of 1H-imidazo[1,2-a]pyrazolo[3,4-c]pyridines. Chem. Pharm. Bull. 1990, 38 (9), 2352-2356.
7. (b) Gueiffier, A,; Blache, Y.; Viols, H.; Chapat, J. P.; Chavignon, O.; Teulade, J. C.; Dauphin, G.; Debouzy, J. C.; Chabart, J. C. Carbon-nitrogen bond formation in cyclisation by deoxygenation, thermolysis or photolysis of phenylimidazo[1,2-a][1,8]naphthyridine. J. Heterocycl. Chem. 1992, 29, 283-287.
8. Elhakmaoui, A.; Gueiffier, A.; Debouzy, J. C.; Blache, Y.; Chavignon, O.; Teulade, J. C.; Milhavet, J. C.; Dauphin, G.; Chapat, J. P. Synthesis of acyclo-C-nucleosides of imidazo[1,2-a]pyridine as potential antiviral agents; Studies of model membrane passage. Boll. Chim. Farm. 1995, submitted.
9. Elhakmaoui, A.; Gueiffier, A.; Milhavet, J. C.; Blache, Y.; Chapat, J. P.; Chavignon, O.; Teulade, J. C.; Snoeck, R.; Andrei, G.; De Clercq, E. Synthesis and antiviral activity of 3-substituted imidazo[1,2-a]pyridine. BioOrg. Med. Chem. Lett. 1994, 4 (16), 1937-1940.
10. Gueiffier, A.; Blache, Y.; Chapat, J. P.; Alhakmaoui, A.; Essassi, E. M.; Andrei, G.; Snoeck, R.; De Clercq, E.; Chavignon, O.; Teulade, J. C.; Fauvelle, F. Synthesis and antiviral activity of 2 and 3-substituted imidazo[1,2-a]pyrimidines. Nucleosides Nucleotides 1995, 14 (3-5), 551-554.
11. Roe, A. M. The thermal condensation of imidazoles with carbonyl compounds. J. Chem. Soc. 1963, 2195-2200.
12. Teulade, J. C.; Bonnet, P. A.; Rieu, J. N.; Viols, H.; Chapat, J. P.; Grassy, G.; Carpy, A. C-3 hydroxylation of some imidazo-[1,2-a]azines, J. Chem. Res. (M) 1986, 1842-1874.
13. (a) De Clercq, E.; Descamps, J.; Verhelst, G.; Walker, R. T.; Jones, A. S.; Torrence, P. F.; Shugar, D. Comparative efficacy of antiherpes drugs against different strains of herpes simplex virus. J. Infect. Dis. 1980,141 (5), 563-574.
14. (b) De Clercq, E. Antiviral and antimetabolic activities of neplanocins. Antimicrob. Agents Chemother. 1985, 28 (1), 84-89.
15. (c) De Clercq, E.; Holy, A.; Rosenberg, I.; Sakuma, T.; Balzarini, J.; Maudgal, P. C. A novel selective broad-spectrum anti-DNA virus agents. Nature 1986, 323 (6087), 464-467.
16. (d) Pauwels, R.; Balarini, J.; Baba, M.; Snoeck, R.; Schols, D.; Herdewijn, P.; Desmyter, J.; De Clercq, E. Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J. Virol. Methods 1988, 20, 309-321.
17. (e) Schols, D.; De Clercq, E.; Balzarini, J.; Baba, M.; Witvrouw, M.; Hosoya, M.; Andrei, G.; Snoeck, R.; Neyts, J.; Pauwels, R.; Nagy, M.; Györgyi-Edelényi, J.; Machovich, R.; Horvath, I.; Löw, M.; Görög, S. Sujphated polymers are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, respiratory synctial virus and toga-, arena- and retroviruses. Antiviral Chem. Chemother. 1990, 1 (4), 233-240.
18. (f) De Clercq, E. in vitro and ex-viro test systems to rationalize drug design and delivery. In Minutes collection; Crommelin, D., Couvreur, P., Duchêne, D., Eds.; 1994; pp 108-125.